| Application no. and date | 12700433.1 (espacenet) (Federated) (European Patent Register), 20120111 | | Patent/reg. no. and date | DK/EP 2663577, 20170412 | | Publication date | 20131120 | | Priority no. and date | US 201161432814 P, 20110114 | | EP pub. no. and date |
EP 2663577 20131120 | | Effective date | | | Applicant/owner | UCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE | | Applicant ref. no. | 160667 | | Inventor | ADAMS, Ralph, c/o IPD UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB,
BAKER, Terence Seward, c/o IPD
UCB Celltech
208 Bath Road
Slough Berkshire SL1 3WE, GB,
LAWSON, Alastair David Griffiths, c/o IPD
UCB Celltech
208 Bath Road
Slough Berkshire SL1 3WE, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C07K 16/24 (2006.01) | | Title | Antistof, der binder sig til IL-17A og IL-17F | | Int. application no. | GB2012050050 | | Int. publication no. | WO2012095662 | | Related patent (certificate) | CA 2022 00002 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
